HomeCPRX • NASDAQ
Catalyst Pharmaceuticals Inc
add
$21.20
1.15%
After Hours:(1.30%)-0.28
$20.93
Closed: Mar 12, 6:11:44 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 141.82M | 28.26% |
Operating expense | 64.41M | -54.89% |
Net income | 55.94M | 60.53% |
Net profit margin | 39.44 | 25.17% |
Earnings per share | 0.70 | 141.38% |
EBITDA | 72.30M | 42.23% |
Effective tax rate | 24.60% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 517.55M | 276.03% |
Total assets | 851.41M | 81.11% |
Total liabilities | 123.78M | 50.52% |
Total equity | 727.63M | — |
Shares outstanding | 121.45M | — |
Price to book | 3.48 | — |
Return on assets | 19.35% | — |
Return on capital | 22.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 55.94M | 60.53% |
Cash from operations | 70.88M | 27.37% |
Cash from investing | -88.00K | 99.77% |
Cash from financing | 4.43M | 766.62% |
Net change in cash | 75.22M | 351.38% |
Free cash flow | 59.70M | 583.53% |
Previous close
$20.96
Day range
$20.89 - $21.42
Year range
$14.47 - $24.64
Market cap
2.53B USD
Avg Volume
1.09M
P/E ratio
16.16
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Headquarters
Website
Employees
181
